|
|
Volumn 46, Issue 4, 2000, Pages 633-637
|
|
Sitafloxacin in the treatment of patients with infections caused by vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMIKACIN;
AMOXICILLIN PLUS CLAVULANIC ACID;
AMPHOTERICIN;
CEFTAZIDIME;
CHLORAMPHENICOL;
CIPROFLOXACIN;
GENTAMICIN;
IMIPENEM;
ITRACONAZOLE;
MEROPENEM;
METICILLIN;
METRONIDAZOLE;
PIPERACILLIN PLUS TAZOBACTAM;
POLYPEPTIDE ANTIBIOTIC AGENT;
QUINOLINE DERIVED ANTIINFECTIVE AGENT;
RIFAMPICIN;
SITAFLOXACIN;
TEICOPLANIN;
VANCOMYCIN;
ADULT;
AGED;
ANTIBIOTIC RESISTANCE;
ARTICLE;
BACTERIAL INFECTION;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONGESTIVE HEART FAILURE;
DEPRESSION;
DIARRHEA;
DRUG EFFICACY;
ENTEROCOCCUS;
EPISTAXIS;
FEMALE;
FEVER;
GRAM POSITIVE BACTERIUM;
HUMAN;
INFECTION;
LIVER DYSFUNCTION;
MALE;
METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS;
MINIMUM INHIBITORY CONCENTRATION;
NEPHROTOXICITY;
PERICARDIAL EFFUSION;
PHASE 2 CLINICAL TRIAL;
PLEURA EFFUSION;
RASH;
SEIZURE;
TACHYCARDIA;
TREATMENT FAILURE;
TREATMENT OUTCOME;
|
|
EID: 0033785516
PISSN: 03057453
EISSN: None
Source Type: Journal
DOI: 10.1093/jac/46.4.633 Document Type: Article |
|
Times cited : (28)
|
|
References (7)
|
